IL33 and neoplasm: Both RNA sequencing and qPCR analysis of samples from an enlarged cohort consisting of 41 patients with CRC showed that the expression of IL33 and its receptor ST2 was higher in tumor tissues than in peritumor and normal tissues, and a higher trend of IL33 expression by tumor tissues was also observed in late-stage patients (Figure S1D-G).